US Patent 11634485 Therapeutic antibody formulation

Patent 11634485 was granted and assigned to Eli Lilly and Company on April, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Eli Lilly

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

116344850

Patent Inventor Names

Vincent John Corvari0

Karthik Pisupati0

Date of Patent

April 25, 2023

Patent Application Number

167872540

Date Filed

February 11, 2020

Patent Citations

‌

US Patent 10000562 Antibody formulations

‌

US Patent 10472416 IL-17 antibody formulations and methods of treatment using same

Patent Primary Examiner

‌

Yunsoo Kim

Stable aqueous pharmaceutical formulations for therapeutic antibodies and methods of using such stable aqueous pharmaceutical formulations.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11634485 Therapeutic antibody formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API